Hagen Kulbe Selected Research

Hagen Kulbe Research Topics

Disease

28	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 11/2005
28	Neoplasms (Cancer) 12/2021 - 01/2004
6	Carcinoma (Carcinomatosis) 01/2022 - 01/2016
5	Ovarian Epithelial Carcinoma 01/2022 - 11/2005
3	Ascites 03/2016 - 07/2007
3	Inflammation (Inflammations) 01/2012 - 07/2005
2	Infections 11/2013 - 03/2011
2	Necrosis 11/2013 - 07/2007
2	Carcinogenesis 06/2011 - 02/2006
2	Neoplasm Metastasis (Metastasis) 07/2007 - 01/2004
2	Extranodal Extension 07/2007 - 01/2007
1	Residual Neoplasm 01/2022
1	Genomic Instability 12/2021
1	Alcoholism (Alcohol Abuse) 10/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2017
1	Vaccinia 11/2013
1	Papilloma (Papillomatosis) 06/2011
1	Clear Cell Adenocarcinoma 04/2011
1	Hypoxia (Hypoxemia) 04/2011
1	Hypercalcemia (Milk Alkali Syndrome) 04/2011
1	Breast Neoplasms (Breast Cancer) 07/2005
1	Pathologic Processes 01/2004

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 03/2016 - 01/2004
9	Interleukin-6 (Interleukin 6)IBA 04/2015 - 02/2006
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2005
7	ChemokinesIBA 01/2014 - 01/2004
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009 - 07/2005
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2018
5	PlatinumIBA 12/2021 - 04/2011
5	Messenger RNA (mRNA)IBA 04/2019 - 11/2005
5	Chemokine ReceptorsIBA 03/2017 - 01/2004
3	LigandsIBA 03/2017 - 01/2004
3	AntibodiesIBA 01/2016 - 01/2012
3	Infliximab (Remicade)FDA Link 03/2011 - 02/2006
3	NF-kappa B (NF-kB)IBA 10/2009 - 07/2005
2	LipidsIBA 04/2021 - 10/2018
2	ParaffinIBA 01/2019 - 12/2018
2	Aldehyde Dehydrogenase 1 FamilyIBA 01/2018 - 01/2017
2	Small Interfering RNA (siRNA)IBA 03/2016 - 01/2012
2	Neutralizing AntibodiesIBA 04/2015 - 01/2012
2	Interleukin-17 (Interleukin 17)IBA 08/2014 - 10/2009
2	Macrophage Migration-Inhibitory FactorsIBA 07/2007 - 01/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2007 - 01/2007
2	Metalloproteases (Metalloproteinases)IBA 04/2006 - 07/2005
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 12/2021
1	AntigensIBA 04/2021
1	CopperIBA 10/2019
1	Disulfiram (Antabuse)FDA Link 10/2019
1	Pharmaceutical PreparationsIBA 10/2019
1	EnzymesIBA 10/2019
1	Cisplatin (Platino)FDA LinkGeneric 10/2019
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 04/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	AldehydesIBA 01/2018
1	silmitasertibIBA 03/2016
1	Protein Kinases (Protein Kinase)IBA 03/2016
1	Casein Kinase II (Casein Kinase 2)IBA 03/2016
1	Phosphotransferases (Kinase)IBA 03/2016
1	B7-H1 AntigenIBA 01/2016
1	Gefitinib (Iressa)FDA Link 04/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2014
1	Lymphotoxin-alpha (Lymphotoxin)IBA 01/2014
1	Lymphotoxin beta ReceptorIBA 01/2014
1	Thymidine KinaseIBA 11/2013
1	HMGB1 Protein (HMG1)IBA 11/2013
1	Adenosine Triphosphate (ATP)IBA 11/2013
1	Caspase 8 (Caspase-8)IBA 11/2013
1	siltuximabIBA 09/2011
1	anthraceneIBA 06/2011
1	terephthalic acid (terephthalate)IBA 06/2011
1	Angiogenesis InhibitorsIBA 04/2011
1	Sunitinib (Sutent)FDA Link 04/2011
1	InterleukinsIBA 04/2011
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 04/2011
1	DNA (Deoxyribonucleic Acid)IBA 04/2011
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2009
1	Type I Tumor Necrosis Factor ReceptorsIBA 10/2009
1	Interleukin-23 (Interleukin 23)IBA 10/2009
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2009
1	Peptides (Polypeptides)IBA 07/2009
1	CTCE-9908IBA 07/2009
1	Interleukin-10 (Interleukin 10)IBA 07/2007
1	Chemotactic FactorsIBA 07/2007
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2007
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2007
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 07/2005
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 07/2005

Therapy/Procedure

6	Therapeutics 12/2021 - 06/2008
1	Investigational Therapies (Experimental Therapy) 01/2017
1	Drug Therapy (Chemotherapy) 04/2011